Jonathan Campbell, Health Consultant
Natural Therapies for Chronic Illness & Health Maintenance


Let thy food be thy medicine, and thy medicine be thy food.
Hippocrates, Father of Medicine, 400 B.C.

ToxicAlert

Helping people take charge of their health

If you or a loved one or friend is afflicted with cancer, heart disease, AIDS, or other chronic illness, click here.

If you use Lipitor, Zocor, or another statin drug to control cholesterol, click here

If you're worried about the economy, click here


Introduction
Order Manuals
Order Consultation
Natural Therapies
Cancer
Cardiovascular Disease
Lipitor Injury
Type II Diabetes
AIDS
Chronic Fatigue
Hepatitis C
Mental Disorders
Sexual Dysfunction
Patient Empowerment
Menopause Naturally
Free Newsletter
Health Forum
HealthAlert
ToxicAlert
EconomicAlert
About Jonathan Campbell
Contact Jonathan Campbell
Home Page

 

The 1994 EPA Dioxin Reassessment

Health Assessment, Volume III: Risk Characterization

9.9. USE OF TOXICITY EQUIVALENCE

The concept of toxicity equivalence in evaluating mixtures of dioxin-like compounds is fundamental to many of the conclusions reached in this characterization. This is based on the fact that most data described in this and preceding chapters were obtained using 2,3,7,8-TCDD as the experimental compound. More limited data exist as individual congeners are evaluated. Nonetheless, estimates of body burden as derived in this reassessment suggest that greater than 90% of the total dioxin equivalence is due to dioxin-like compounds other than 2,3,7,8-TCDD. While there are empirical bases for the toxicity equivalence factors assigned to dioxin-like compounds relative to 2,3,7,8-TCDD, they generally represent order of magnitude estimates of relative toxicity and are not meant to be used precisely. The potency for most, if not all, of the toxic end points is determined by the number and position of the halogen (chlorine or bromine) atoms on the dioxin-like molecule. This appears, based on a substantial body of evidence, to be a function of relative ability to bind to a specific cellular receptor that mediates most, if not all, of the toxic end points of this class of compounds. This inference is based on experimental evidence, primarily in rodents but involving some other species, that for some toxic effects, the potency of the effect itself is proportional to receptor binding as measured by either binding studies or a sensitive measure of receptor binding, AHH induction. When ED50s for effects versus binding are plotted logarithmically, good linear correlations are obtained (Safe, 1990). This approach constitutes a "relative ranking" scheme based on 2,3,7,8-TCDD. Because the data base for effects for individual congeners is incomplete and because the concept is based on responsiveness of humans to these compounds in a manner similar to that of animals and high to low dose extrapolation, the TEQ approach is considered a useful but uncertain procedure.

In addition to the idea of "relative ranking," there is a second aspect to the TEQ approach. This is the concept of additivity. The hypothesis is that one can estimate the toxicity of a mixture of dioxin-like compounds by adding together the products of the concentrations of the individual congeners and their TEFs. This hypothesis has not been extensively tested although data addressing this issue are generally supportive of additivity. Some data collected using high levels of different congeners have suggested the potential for interactions (mostly, antagonism) between congeners. There is currently general acceptance of the concept of additivity with the recognition that issues such as congener interactions, presence of "spare" receptors, and the unavoidable presence of other dietary constituents that react with the dioxin receptor must be considered to add uncertainty to the concept.

The points discussed above describe the basis of the TEQ concept and indicate some of the assumptions on which they are based. A more detailed description of these issues is contained in U.S. EPA (1989). In addition to scientific grounds, the use of TEQs can be justified on a practical basis, not the least of which is the sheer enormity of the task of attempting to conduct appropriate studies on all toxic end points for all of the congeners. They continue to be described by the EPA and others as an "interim" approach, and the extent of their current use should not detract from the expressed need for more data to further validate their use.

 Continue to 9.10



Back to the Natural Therapy Virtual Clinic

Order a Natural Therapy Manual or Contact Jonathan Campbell

©Graphics, Web design, and content Copyright 2003-2006 by Jonathan L. Campbell.


Jonathan Campbell, Health Consultant
43 Boynton Street, S. 2R
Boston, MA 02130-3263

Jonathan regrets that, because of time constraints, he cannot respond
to individual phone or email messages outside of prepaid consultations.

To set up a consultation, please click here.

http://www.cqs.com


Stop Spam - Subscribe to SpamCop - http://www.spamcop.net